_id
6910998eccc777a4e85d5c81
Ticker
EVAX
Name
Evaxion Biotech AS
Exchange
NASDAQ
Address
Dr. Neergaards Vej, Horsholm, Denmark, 2970
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://evaxion.ai
Description
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based cancer vaccine that has completed Phase 1/2a trial to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers, including non-small cell lung cancer. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1 for the prevention of S. aureus-induced skin and soft tissue infections in patients undergoing elective abdominal hernia surgery; EVX-B2 to target diseases caused by N. gonorrhoeae; EVX-B3 for eliciting strong humoral antibody and cellular immune response to the bacterial pathogen; and EVX-V1, a viral vaccine product candidate for targeting Cytomegalovirus. The company was formerly known as Evaxion Biotech A/S and changed its name to Evaxion A/S in May 2025. Evaxion A/S was incorporated in 2008 and is based in Horsholm, Denmark.
Last Close
6.45
Volume
64105
Current Price
6.21
Change
-3.720930232558143
Last Updated
2025-11-30T18:25:36.886Z
Image
data:image/webp;base64,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
Ipo Date
2021-02-05T00:00:00.000Z
Market Cap
49499176
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.23676923076923073
Sentiment Sources
13
Rating
4.5
Target Price
14.175
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
7492000
Cost Of Revenue
-
Gross Profit
7492000
Operating Expenses
4470000
Operating Income
3022000
Interest Expense
1360000
Pretax Income
4352000
Net Income
4618000
Eps
4.178251558248971
Dividends Per Share
-
Shares Outstanding
8340215
Income Tax Expense
-265000
EBITDA
5712000
Operating Margin
40.336358782701545
Total Other Income Expense Net
1330000
Cash
10572000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
10572000
Property Plant Equipment
-
Total Assets
29737000
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
13138000
Equity
16599000
Depreciation
90750
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
PE
-
PB
0.4134938170974155
ROE
27.820953069462018
ROA
15.52947506473417
FCF
-
Fcf Percent
-
Piotroski FScore
2
Health Score
77
Deep Value Investing Score
7.5
Defensive Investing Score
4.5
Dividend Investing Score
1.5
Economic Moat Investing Score
9
Garp Investing Score
5.5
Growth Investing Score
4.5
Momentum Investing Score
5
Net Net Investing Score
2.5
Quality Investing Score
7
Value Investing Score
9.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
7492000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
7492000
Quarters > 0 > income Statement > operating Expenses
4470000
Quarters > 0 > income Statement > operating Income
3022000
Quarters > 0 > income Statement > interest Expense
1360000
Quarters > 0 > income Statement > pretax Income
4352000
Quarters > 0 > income Statement > net Income
4618000
Quarters > 0 > income Statement > eps
4.178251558248971
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1105247
Quarters > 0 > income Statement > income Tax Expense
-265000
Quarters > 0 > income Statement > EBITDA
5712000
Quarters > 0 > income Statement > operating Margin
40.336358782701545
Quarters > 0 > income Statement > total Other Income Expense Net
1330000
Quarters > 0 > balance Sheet > cash
10572000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
10572000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
29737000
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
13138000
Quarters > 0 > balance Sheet > equity
16599000
Quarters > 0 > cash Flow > net Income
4618000
Quarters > 0 > cash Flow > depreciation
90750
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > ratios > PE
4.178251558248971
Quarters > 0 > ratios > PB
0.4134938170974155
Quarters > 0 > ratios > ROE
27.820953069462018
Quarters > 0 > ratios > ROA
15.52947506473417
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
77
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
37000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
37000
Quarters > 1 > income Statement > operating Expenses
4377000
Quarters > 1 > income Statement > operating Income
-4340000
Quarters > 1 > income Statement > interest Expense
241000
Quarters > 1 > income Statement > pretax Income
-5026000
Quarters > 1 > income Statement > net Income
-4831000
Quarters > 1 > income Statement > eps
-4.370968661303763
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1105247
Quarters > 1 > income Statement > income Tax Expense
-195000
Quarters > 1 > income Statement > EBITDA
-4785000
Quarters > 1 > income Statement > operating Margin
-11729.72972972973
Quarters > 1 > income Statement > total Other Income Expense Net
-686000
Quarters > 1 > balance Sheet > cash
14746000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
864018
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
18177000
Quarters > 1 > balance Sheet > property Plant Equipment
3623000
Quarters > 1 > balance Sheet > total Assets
22449000
Quarters > 1 > balance Sheet > payables
2496000
Quarters > 1 > balance Sheet > short Term Debt
540000
Quarters > 1 > balance Sheet > long Term Debt
9031000
Quarters > 1 > balance Sheet > total Liabilities
16223000
Quarters > 1 > balance Sheet > equity
6226000
Quarters > 1 > cash Flow > net Income
-4831000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > ratios > PE
-4.370968661303763
Quarters > 1 > ratios > PB
1.1024066607773852
Quarters > 1 > ratios > ROE
-77.59396080950852
Quarters > 1 > ratios > ROA
-21.519889527373156
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
28
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
122000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
122000
Quarters > 2 > income Statement > operating Expenses
3868000
Quarters > 2 > income Statement > operating Income
-3868000
Quarters > 2 > income Statement > interest Expense
397000
Quarters > 2 > income Statement > pretax Income
-1772000
Quarters > 2 > income Statement > net Income
-1580000
Quarters > 2 > income Statement > eps
-1.429544708105971
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1105247
Quarters > 2 > income Statement > income Tax Expense
-192000
Quarters > 2 > income Statement > EBITDA
-1375000
Quarters > 2 > income Statement > operating Margin
-3170.4918032786886
Quarters > 2 > income Statement > total Other Income Expense Net
2096000
Quarters > 2 > balance Sheet > cash
17843000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1858000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
17843000
Quarters > 2 > balance Sheet > property Plant Equipment
3514000
Quarters > 2 > balance Sheet > total Assets
25239000
Quarters > 2 > balance Sheet > payables
2968000
Quarters > 2 > balance Sheet > short Term Debt
473000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
14918000
Quarters > 2 > balance Sheet > equity
10321000
Quarters > 2 > cash Flow > net Income
-1580000
Quarters > 2 > cash Flow > depreciation
90750
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
1376140
Quarters > 2 > ratios > PE
-1.429544708105971
Quarters > 2 > ratios > PB
0.6650115172948358
Quarters > 2 > ratios > ROE
-15.308594128475923
Quarters > 2 > ratios > ROA
-6.2601529379135465
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
122000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
4146000
Quarters > 3 > income Statement > operating Income
-4024000
Quarters > 3 > income Statement > interest Expense
1703000
Quarters > 3 > income Statement > pretax Income
-3904000
Quarters > 3 > income Statement > net Income
-3629000
Quarters > 3 > income Statement > eps
-0.0517463457725902
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
70130556
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-3298.360655737705
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > balance Sheet > cash
5052000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
8765000
Quarters > 3 > balance Sheet > property Plant Equipment
3514000
Quarters > 3 > balance Sheet > total Assets
12485000
Quarters > 3 > balance Sheet > payables
2968000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
8008000
Quarters > 3 > balance Sheet > total Liabilities
14137000
Quarters > 3 > balance Sheet > equity
-1652000
Quarters > 3 > cash Flow > net Income
-3629000
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > ratios > PE
-0.0517463457725902
Quarters > 3 > ratios > PB
-263.6263636561743
Quarters > 3 > ratios > ROE
219.6731234866828
Quarters > 3 > ratios > ROA
-29.06688025630757
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
38
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
3344000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
3344000
Annuals > 0 > income Statement > operating Expenses
18076000
Annuals > 0 > income Statement > operating Income
-14732000
Annuals > 0 > income Statement > interest Expense
962000
Annuals > 0 > income Statement > pretax Income
-11355000
Annuals > 0 > income Statement > net Income
-10567000
Annuals > 0 > income Statement > eps
-9.849108342055889
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1072889
Annuals > 0 > income Statement > income Tax Expense
-788000
Annuals > 0 > income Statement > EBITDA
-9786000
Annuals > 0 > income Statement > operating Margin
-440.55023923444975
Annuals > 0 > income Statement > total Other Income Expense Net
3377000
Annuals > 0 > balance Sheet > cash
5052000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1858000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
8765000
Annuals > 0 > balance Sheet > property Plant Equipment
3514000
Annuals > 0 > balance Sheet > total Assets
12485000
Annuals > 0 > balance Sheet > payables
2968000
Annuals > 0 > balance Sheet > short Term Debt
473000
Annuals > 0 > balance Sheet > long Term Debt
8008000
Annuals > 0 > balance Sheet > total Liabilities
14137000
Annuals > 0 > balance Sheet > equity
-1652000
Annuals > 0 > cash Flow > net Income
-10567000
Annuals > 0 > cash Flow > depreciation
607000
Annuals > 0 > cash Flow > change In Working Capital
520000
Annuals > 0 > cash Flow > cash From Operations
-12940000
Annuals > 0 > cash Flow > capital Expenditures
4.69
Annuals > 0 > cash Flow > cash From Investing
-3000
Annuals > 0 > cash Flow > cash From Financing
13129000
Annuals > 0 > cash Flow > net Change In Cash
369000
Annuals > 0 > ratios > PE
-9.849108342055889
Annuals > 0 > ratios > PB
-3.8544771277239707
Annuals > 0 > ratios > ROE
639.6489104116223
Annuals > 0 > ratios > ROA
-84.63756507809371
Annuals > 0 > ratios > FCF
-12940004.69
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-3.8696186273923443
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
73000
Annuals > 1 > income Statement > cost Of Revenue
112
Annuals > 1 > income Statement > gross Profit
73000
Annuals > 1 > income Statement > operating Expenses
22270000
Annuals > 1 > income Statement > operating Income
-22197000
Annuals > 1 > income Statement > interest Expense
897000
Annuals > 1 > income Statement > pretax Income
-22915000
Annuals > 1 > income Statement > net Income
-22125000
Annuals > 1 > income Statement > eps
-32.37512712267429
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
683395
Annuals > 1 > income Statement > income Tax Expense
-790000
Annuals > 1 > income Statement > EBITDA
-21403000
Annuals > 1 > income Statement > operating Margin
-30406.849315068495
Annuals > 1 > income Statement > total Other Income Expense Net
-718000
Annuals > 1 > balance Sheet > cash
5583000
Annuals > 1 > balance Sheet > short Term Investments
165
Annuals > 1 > balance Sheet > receivables
1075000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
8350000
Annuals > 1 > balance Sheet > property Plant Equipment
4343000
Annuals > 1 > balance Sheet > total Assets
12889000
Annuals > 1 > balance Sheet > payables
2689000
Annuals > 1 > balance Sheet > short Term Debt
485000
Annuals > 1 > balance Sheet > long Term Debt
8489000
Annuals > 1 > balance Sheet > total Liabilities
17618000
Annuals > 1 > balance Sheet > equity
-4729000
Annuals > 1 > cash Flow > net Income
-22125000
Annuals > 1 > cash Flow > depreciation
615000
Annuals > 1 > cash Flow > change In Working Capital
1562000
Annuals > 1 > cash Flow > cash From Operations
-17691000
Annuals > 1 > cash Flow > capital Expenditures
87000
Annuals > 1 > cash Flow > cash From Investing
-93000
Annuals > 1 > cash Flow > cash From Financing
10691000
Annuals > 1 > cash Flow > net Change In Cash
-7601000
Annuals > 1 > ratios > PE
-32.37512712267429
Annuals > 1 > ratios > PB
-0.8576758987100866
Annuals > 1 > ratios > ROE
467.85789807570313
Annuals > 1 > ratios > ROA
-171.65800294825044
Annuals > 1 > ratios > FCF
-17778000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-243.53424657534248
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
571319
Annuals > 2 > income Statement > gross Profit
-571319
Annuals > 2 > income Statement > operating Expenses
25264000
Annuals > 2 > income Statement > operating Income
-25264000
Annuals > 2 > income Statement > interest Expense
1508000
Annuals > 2 > income Statement > pretax Income
-23941000
Annuals > 2 > income Statement > net Income
-23169000
Annuals > 2 > income Statement > eps
-39.205234810065534
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
590967
Annuals > 2 > income Statement > income Tax Expense
-772000
Annuals > 2 > income Statement > EBITDA
-22572000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1323000
Annuals > 2 > balance Sheet > cash
13184000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1307000
Annuals > 2 > balance Sheet > inventories
-2494064
Annuals > 2 > balance Sheet > total Current Assets
16985000
Annuals > 2 > balance Sheet > property Plant Equipment
4675000
Annuals > 2 > balance Sheet > total Assets
22025000
Annuals > 2 > balance Sheet > payables
2085000
Annuals > 2 > balance Sheet > short Term Debt
439000
Annuals > 2 > balance Sheet > long Term Debt
7864000
Annuals > 2 > balance Sheet > total Liabilities
13722000
Annuals > 2 > balance Sheet > equity
8303000
Annuals > 2 > cash Flow > net Income
-23169000
Annuals > 2 > cash Flow > depreciation
571000
Annuals > 2 > cash Flow > change In Working Capital
-2877000
Annuals > 2 > cash Flow > cash From Operations
-25774000
Annuals > 2 > cash Flow > capital Expenditures
292000
Annuals > 2 > cash Flow > cash From Investing
-268000
Annuals > 2 > cash Flow > cash From Financing
7853000
Annuals > 2 > cash Flow > net Change In Cash
-18982000
Annuals > 2 > ratios > PE
-39.205234810065534
Annuals > 2 > ratios > PB
0.4224243219318318
Annuals > 2 > ratios > ROE
-279.04371913766107
Annuals > 2 > ratios > ROA
-105.19409761634506
Annuals > 2 > ratios > FCF
-26066000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
24
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
343452
Annuals > 3 > income Statement > gross Profit
-343452
Annuals > 3 > income Statement > operating Expenses
25834000
Annuals > 3 > income Statement > operating Income
-25834000
Annuals > 3 > income Statement > interest Expense
915000
Annuals > 3 > income Statement > pretax Income
-24710000
Annuals > 3 > income Statement > net Income
-24532000
Annuals > 3 > income Statement > eps
-50.33981220040712
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
487328
Annuals > 3 > income Statement > income Tax Expense
-178000
Annuals > 3 > income Statement > EBITDA
-24207000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
1124000
Annuals > 3 > balance Sheet > cash
32165999
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1901008
Annuals > 3 > balance Sheet > inventories
-1901000
Annuals > 3 > balance Sheet > total Current Assets
34705000
Annuals > 3 > balance Sheet > property Plant Equipment
5174000
Annuals > 3 > balance Sheet > total Assets
40163000
Annuals > 3 > balance Sheet > payables
2848000
Annuals > 3 > balance Sheet > short Term Debt
440000
Annuals > 3 > balance Sheet > long Term Debt
1044000
Annuals > 3 > balance Sheet > total Liabilities
7726001
Annuals > 3 > balance Sheet > equity
32436999
Annuals > 3 > cash Flow > net Income
-24532000
Annuals > 3 > cash Flow > depreciation
344000
Annuals > 3 > cash Flow > change In Working Capital
1237000
Annuals > 3 > cash Flow > cash From Operations
-21933000
Annuals > 3 > cash Flow > capital Expenditures
1360000
Annuals > 3 > cash Flow > cash From Investing
-1330000
Annuals > 3 > cash Flow > cash From Financing
49805000
Annuals > 3 > cash Flow > net Change In Cash
26332000
Annuals > 3 > ratios > PE
-50.33981220040712
Annuals > 3 > ratios > PB
0.0891664386091944
Annuals > 3 > ratios > ROE
-75.62968448468368
Annuals > 3 > ratios > ROA
-61.08109453975052
Annuals > 3 > ratios > FCF
-23293000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
4.178251558248971
Valuation > metrics > PB
0.4134938170974155
Valuation > final Score
90
Valuation > verdict
58.4% Undervalued
Profitability > metrics > ROE
27.820953069462018
Profitability > metrics > ROA
43.68142262580401
Profitability > metrics > Net Margin
0.6163908168713295
Profitability > final Score
100
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.7914934634616543
Risk > metrics > Interest Coverage
2.222058823529412
Risk > final Score
57
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
80
Prev Valuations > 1
70
Prev Valuations > 2
50
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
40
Prev Risks > 0
-54
Prev Risks > 1
-9
Prev Risks > 2
21
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:27:03.824Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.01
Earnings History > 0 > eps Estimate
-0.01
Earnings History > 0 > eps Difference
0.02
Earnings History > 0 > surprise Percent
200
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1
Earnings History > 1 > eps Estimate
-0.45
Earnings History > 1 > eps Difference
-0.55
Earnings History > 1 > surprise Percent
-122.2222
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-26
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-3.1437
Earnings History > 2 > eps Estimate
-0.705
Earnings History > 2 > eps Difference
-2.4387
Earnings History > 2 > surprise Percent
-345.9149
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-25
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.07
Earnings History > 3 > eps Estimate
-0.15
Earnings History > 3 > eps Difference
0.08
Earnings History > 3 > surprise Percent
53.3333
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-10-31
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.04
Earnings History > 4 > eps Estimate
-0.31
Earnings History > 4 > eps Difference
0.27
Earnings History > 4 > surprise Percent
87.0968
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-14
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.12
Earnings History > 5 > eps Estimate
-0.39
Earnings History > 5 > eps Difference
0.27
Earnings History > 5 > surprise Percent
69.2308
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-28
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.3
Earnings History > 6 > eps Estimate
-0.56
Earnings History > 6 > eps Difference
0.86
Earnings History > 6 > surprise Percent
153.5714
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-26
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-1.6
Earnings History > 7 > eps Estimate
-1.6
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
0
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-12-19
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.21
Earnings History > 8 > eps Estimate
-0.19
Earnings History > 8 > eps Difference
-0.02
Earnings History > 8 > surprise Percent
-10.5263
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-18
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.21
Earnings History > 9 > eps Estimate
-0.21
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
0
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.24
Earnings History > 10 > eps Estimate
-0.24
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
0
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2022-12-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-2.9
Earnings History > 11 > eps Estimate
-2.63
Earnings History > 11 > eps Difference
-0.27
Earnings History > 11 > surprise Percent
-10.2662
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.24
Earnings History > 12 > eps Estimate
-0.27
Earnings History > 12 > eps Difference
0.03
Earnings History > 12 > surprise Percent
11.1111
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-10
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.2
Earnings History > 13 > eps Estimate
-0.3
Earnings History > 13 > eps Difference
0.1
Earnings History > 13 > surprise Percent
33.3333
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-11
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.25
Earnings History > 14 > eps Estimate
-0.33
Earnings History > 14 > eps Difference
0.08
Earnings History > 14 > surprise Percent
24.2424
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-22
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.39
Earnings History > 15 > eps Estimate
-0.29
Earnings History > 15 > eps Difference
-0.1
Earnings History > 15 > surprise Percent
-34.4828
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-09
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.27
Earnings History > 16 > eps Estimate
-0.34
Earnings History > 16 > eps Difference
0.07
Earnings History > 16 > surprise Percent
20.5882
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.36
Earnings History > 17 > eps Estimate
-0.29
Earnings History > 17 > eps Difference
-0.07
Earnings History > 17 > surprise Percent
-24.1379
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.23
Earnings History > 18 > eps Estimate
-0.3
Earnings History > 18 > eps Difference
0.07
Earnings History > 18 > surprise Percent
23.3333
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-01-25
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.19
Earnings History > 19 > eps Estimate
-0.25
Earnings History > 19 > eps Difference
0.06
Earnings History > 19 > surprise Percent
24
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based cancer vaccine that has completed Phase 1/2a trial to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers, including non-small cell lung cancer. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1 for the prevention of S. aureus-induced skin and soft tissue infections in patients undergoing elective abdominal hernia surgery; EVX-B2 to target diseases caused by N. gonorrhoeae; EVX-B3 for eliciting strong humoral antibody and cellular immune response to the bacterial pathogen; and EVX-V1, a viral vaccine product candidate for targeting Cytomegalovirus. The company was formerly known as Evaxion Biotech A/S and changed its name to Evaxion A/S in May 2025. Evaxion A/S was incorporated in 2008 and is based in Horsholm, Denmark.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AS P Trends: Will EVAX stock gain from strong economy - Earnings Trend Report & Real-Time Chart Breakout Alerts moha.gov.vn
Read more →Evaxion Biotech stock holds Buy rating at H.C. Wainwright after ASH data Investing.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$14.175
Analyst Picks
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 1.91% of the total shares of Evaxion Biotech AS
1.
Ikarian Capital, LLC(1.2665%)
since
2025/06/30
2.
BOOTHBAY FUND MANAGEMENT, LLC(0.3756%)
since
2025/06/30
3.
Rhumbline Advisers(0.1494%)
since
2025/06/30
4.
GAMMA Investing LLC(0.0553%)
since
2025/06/30
5.
UBS Group AG(0.0323%)
since
2025/06/30
6.
Beacon Capital Management, LLC(0.0154%)
since
2025/06/30
7.
Fidelity Nasdaq Composite Index(0.0098%)
since
2025/07/31
8.
SBI Securities Co Ltd(0.001%)
since
2025/06/30
9.
Advisor Group Holdings, Inc.(0.0004%)
since
2025/06/30
10.
SouthState Bank Corp(0%)
since
2025/03/31
11.
Millennium Management LLC(0%)
since
2025/03/31
12.
JPMorgan Chase & Co(0%)
since
2025/03/31
13.
Armistice Capital, LLC(0%)
since
2025/03/31
14.
XTX Topco Ltd(0%)
since
2025/06/30
15.
Invst LLC(0%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.01
EPS Estimate
-0.01
EPS Difference
0.02
Surprise Percent
200%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.